ACP 2010 Resources

Article

Course Information

Handouts

 

Courses for Hospitalists

 

Courses for Allied Health Professionals

 

Courses for Academic Physicians

 

Previous Coverage

2009 Coverage

 

Connect

On Twitter

 

On Facebook

 

More Resources

Conference recordings and webcasts

 

ACP website

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
The ACIP Meets on September 18 as Vaccine Policy Hangs in the Balance / image credit©Davizro Photography/stock.adobe.com

The ACIP Meets on September 18 as Vaccine Policy Hangs in the Balance

Richard Payerchin
September 18th 2025
Article
Weekly Dose Podcast: Cervical Cancer Disparities, HPV Awareness Gaps, Depression Risk After Diagnosis, PharmFIT Preferences, and Semaglutide for MASH

Weekly Dose Podcast: Cervical Cancer Disparities, HPV Awareness Gaps, Depression Risk After Diagnosis, PharmFIT Preferences, and Semaglutide for MASH

Sydney Jennings
September 18th 2025
Podcast
Investigational Oral GLP-1 RA, Orforglipron, Yields Dose-Dependent Weight Loss in Phase 3 Trial

Investigational Oral GLP-1 RA, Orforglipron, Yields Dose-Dependent Weight Loss in Phase 3 Trial

Sydney Jennings
September 18th 2025
Article
Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Sydney Jennings
September 18th 2025
Podcast
Implantable Neuromodulation Device Shows Sustained Benefit in Chronic Migraine at 12 Months

Implantable Neuromodulation Device Shows Sustained Benefit in Chronic Migraine at 12 Months

Grace Halsey
September 18th 2025
Article
Amylin Injectable Cagrilintide Demonstrates Weight Loss of 11.8% in Late-Stage Trial: Novo Nordisk Update / image credit Timothy Garvey, MD courtesy of University of Alabama at Birmingham

Amylin Injectable Cagrilintide Demonstrates Weight Loss of 11.8% in Late-Stage Trial: Novo Nordisk Update

Grace Halsey
September 18th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.